Ann Leen, Ph.D

Ann+Leen+%283C%29.jpg

Ann Leen, Ph.D.

Chief Scientific Officer

Dr. Ann Leen is a co-founder and serves as the Chief Scientific Officer of AlloVir. She has more than 7 years of industry experience and >20 years of basic and translational science experience in academia. She is based at the Center for Cell and Gene Therapy, Baylor College of Medicine, Houston where she holds the title of Professor in the Dept. of Pediatrics. She has developed and translated multiple novel T cell based therapies from the bench to the bedside. Indeed, she is currently the principal investigator (PI) on 5 investigator-initiated Investigational New Drug (IND) studies and over the past 10 years has served as PI on >10 clinical trials using “first in man” cell therapies for patients.

Ann is senior or co-author on >90 publications and a named inventor on 14 published patents. She received her B.S. in Biochemistry at the University of College Cork in Cork, Ireland and her Ph.D. in Immunology at the CRC Institute for Cancer Studies in Birmingham, UK.